The short answer: Yes, experience can matter. In advanced ovarian cancer, women who have all visible cancer removed tend to live longer, and research shows that hospitals and teams that do this surgery regularly are more likely to achieve complete removal and have fewer deaths after surgery. Experience is one important factor among several: how far the cancer has spread, its type, your general health and the chemotherapy and maintenance treatment that follow also matter.
Families often search for an “ovarian cancer surgeon” or, in Hindi, अंडाशय के कैंसर का ऑपरेशन (andashay ke cancer ka operation). This page explains what to ask. For the full picture of ovarian cancer diagnosis and treatment, read our main guide.
On this page
- The CC score
- What research shows about experience
- Centre volume effect
- Questions to ask
- How to find the right surgeon
The Cytoreduction Completeness (CC) Score
After surgery, the surgeon records how much cancer could not be removed (residual disease):
- CC-0: no visible residual disease
- CC-1: residual disease ≤ 2.5mm
- CC-2: residual disease 2.5mm–2.5cm
- CC-3: residual disease > 2.5cm
In studies, women with no visible cancer left (CC-0) live longer, on average, than women with small amounts left, who in turn do better than women with larger amounts left. The main aim of surgery is therefore to leave no visible cancer, when this can be done safely. Ovarian cancer reports often describe the same idea in other words, such as “no visible residual disease”, “less than 1 cm left” or “more than 1 cm left”.
What Research Shows About Experience
Most research compares hospitals and teams rather than individual surgeons:
- A 2025 review of 15 studies including more than 100,000 women found that most studies linked treatment at hospitals doing more ovarian cancer surgery with longer survival, more complete surgery and fewer deaths after surgery.
- An older review of 81 groups of patients found that groups in which more women had the bulk of their cancer removed lived longer on average.
- There is no single agreed number of operations that makes a surgeon or hospital “high volume”; studies use different cut-offs.
Centre volume effect
Centre infrastructure matters independent of surgeon volume:
- Multidisciplinary tumour board availability
- Intra-operative imaging and frozen section pathology
- ICU and blood bank capacity
- Trained anaesthesia and perioperative team
- Specialised nursing
An experienced gynaecological cancer surgeon working in a hospital with this support is the combination most studies favour.
Questions to ask
- How many ovarian cancer debulking operations do you and your team do each year?
- How often are you able to remove all visible cancer (CC-0)?
- How often do patients have serious complications or die within 30 days of this surgery?
- Do you recommend surgery first or chemotherapy first for me, and why?
- Has my case been discussed by a multidisciplinary team (tumour board)?
- Where do you share or publish your results?
A good team will discuss these questions openly and explain what applies to your case.
How to find the right surgeon
- Look for fellowship training specifically in gynaecological oncology
- Check society memberships (ESGO, IGCS, IAGO)
- Look at publications — academic engagement signals ongoing practice refinement
- Ask for case volume directly
- Consider a second opinion before committing
See cytoreductive surgery overview and 9 factors affecting HIPEC success.
FAQs
What if my local hospital does cytoreductive surgery occasionally?
Experience matters, but there is no single magic number. If your local hospital rarely does this operation, ask how many it does, whether a gynaecological cancer specialist will operate and whether intensive care support is available. Getting a specialist opinion, or travelling to a centre that does this surgery regularly, is worth discussing with your referring doctor.
Is centre prestige the same as volume?
No. A well-known hospital name does not always mean a high number of cases for your specific operation. Ask for actual numbers.
What is Dr. Nishtha's case volume?
Dr. Nishtha is happy to discuss her case numbers and results directly during consultation. When HIPEC is advised with cytoreductive surgery, it is done at Sterling Hospitals and KD Hospital.
Does laparoscopic cytoreduction work?
Generally no for advanced ovarian cancer. Open surgery is the standard. Selected early-stage disease may be staged minimally invasively.
Why doesn't the chemotherapy compensate for incomplete surgery?
Chemotherapy works best when only tiny amounts of cancer remain. Larger amounts of leftover cancer (CC-2/3) are harder for chemotherapy to control. This is why the completeness of surgery matters even when chemotherapy follows. Read about how chemotherapy fits into treatment; the order of surgery and chemotherapy is decided for each patient.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. To book: WhatsApp +91 76988 00333.